Gene therapy: New developments;Gentherapie: Neue entwicklungen

Praxis

Volumn 91, Issue 51-52, 2002, Pages 2227-2235

  Mohr, L ^a   Geissler, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

DNA vaccine; Gene transfer; Nonviral vectors; Oncolytic viruses; Viral vectors

Indexed keywords

DNA VACCINE; IMMUNOLOGICAL ADJUVANT;

ADENOVIRUS; ANIMAL; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC DISORDER; GENETICS; HEMATOPOIETIC STEM CELL; HERPES VIRUS; HUMAN; LENTIVIRINAE; METABOLISM; NEOPLASM; PHASE 1 CLINICAL TRIAL; RETROVIRUS; REVIEW; VIRUS; VIRUS GENE; VIRUS REPLICATION;

ADENOVIRIDAE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CLINICAL TRIALS, PHASE I; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC DISEASES, INBORN; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HERPESVIRIDAE; HUMANS; LENTIVIRUS; NEOPLASMS; RETROVIRIDAE; VACCINES, DNA; VIRUS REPLICATION; VIRUSES;

EID: 0037132777     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.91.51.2227     Document Type: Review

References (88)

1. Mulligan R.C.: The basic science of gene therapy, Science 260, 926-932, 1993.
2. Marshall E.: Gene therapy death prompts review of adenovirus vector, Science 286, 2244-2245, 1999.
3. Balter M.: Training viruses to attack cancer, Science 282, 1244-1246, 1998.
4. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L.: Direct gene transfer into mouse muscle in vivo, Science 247, 1465-1468, 1990.
5. Yang N.S., Burkholder J., Roberts B., Martinell B., McCabe D.: In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment, Proc. Natl. Acad. Sci. USA 87, 9568-9572, 1990. (Pubitemid 120016484)
6. Walther W., Stein U., Fichtner I., Malcherek L., Lemm M., Schlag P.M.: Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology, Gene. Ther. 8, 173-180, 2001. (Pubitemid 32186128)
7. Rols M.P., Delteil C., Golzio M., Dumond P., Cros S., Teissie J.: In vivo electrically mediated protein and gene transfer in murine melanoma, Nat. Biotechnol. 16, 168-171, 1998. (Pubitemid 28078505)
8. Roth D.A., Tawa N.E., Jr., O'Brien J.M., Treco D.A., Selden R.F.: Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A, N. Engl. J. Med. 344, 1735-1742, 2001. (Pubitemid 32497027)
9. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., et al.: Heterologous protection against influenza by injection of DNA encoding a viral protein, Science 259, 1745-1749, 1993. (Pubitemid 23114660)
10. Xiang Z., Ertl H.C.: Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines, Immunity 2, 129-135, 1995.
11. Restifo N.P., Ying H., Hwang L. Leitner W.W.: The promise of nucleic acid vaccines, Gene Ther. 7, 89-92, 2000. (Pubitemid 30088954)
12. Grimm C.F., Ortmann D., Mohr L., Michalak S., Krohne T.U., Meckel S., Eisele S., Encke J., Blum H.E., Geissler M.: Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice, Gastroenterology 119, 1104-1112, 2000.
13. Vollmer C.M., Jr., Eilber F.C., Butterfield L.H., Ribas A., Dissette V.B., Koh A., Montejo L.D., Lee M.C., Andrews K.J., McBride W.H., Glaspy J.A., Economou J.S.: Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma, Cancer Res. 59, 3064-3067, 1999. (Pubitemid 29316002)
14. Ying H., Zaks T.Z., Wang R.F., Irvine K.R., Kammula U.S., Marincola F.M., Leitner W.W., Restifo N.P.: Cancer therapy using a self-replicating RNA vaccine, Nat. Med. 5, 823-827, 1999. (Pubitemid 29318618)
15. Leitner W.W., Ying H., Driver D.A., Dubensky T.W., Restifo N.P.: Enhancement of tumor-specific immune response with plasmid DNA replicon vectors, Cancer Res. 60, 51-55, 2000. (Pubitemid 30058729)
16. Cheng W.F., Hung C.H., Chai C.Y., Hsu K.F., He L., Ling M., Wu T.C.: Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen, J. Virol. 75, 2368-2376, 2001. (Pubitemid 32147575)
17. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., Danielsen M.: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure, Proc. Natl. Acad. Sci. USA 84, 7413-7417, 1987.
18. Abdallah B., Hassan A., Benoist C., Goula D., Behr J.P., Demeneix B.A.: A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine, Hum. Gene. Ther. 7, 1947-1954, 1996. (Pubitemid 26390233)
19. Goldman C.K., Soroceanu L., Smith N., Gillespie G.Y., Shaw W., Burgess S., Bilbao G., Curiel D.T.: In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer, Nat. Biotechnol. 15, 462-466, 1997. (Pubitemid 27197645)
20. Nishikawa M., Huang L.: Nonviral vectors in the new millennium: delivery barriers in gene transfer, Hum. Gene. Ther. 12, 861-870, 2001. (Pubitemid 32681851)
21. Plank C., Mechtler K., Szoka F.C., Jr., Wagner E.: Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery, Hum. Gene. Ther. 7, 1437-1446, 1996. (Pubitemid 26293564)
22. Mohr L., Yoon S.K., Eastman S.J., Chu Q., Scheule R.K., Scaglioni P.P., Geissler M., Heintges T., Blum H.E., Wands J.R.: Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice, Hum. Gene. Ther. 12, 799-809, 2001. (Pubitemid 32692345)
23. Nabel G.J., Nabel E.G., Yang Z.Y., Fox B.A., Plautz G.E., Gao X., Huang L., Shu S., Gordon D., Chang A.E.: Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans, Proc. Natl. Acad. Sci. USA 90, 11307-11311, 1993. (Pubitemid 23354418)
24. Mohr L., Schauer J.I., Boutin R.H., Moradpour D., Wands J.R.: Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody-based gene delivery system, Hepatology 29, 82-89, 1999. (Pubitemid 29023990)
25. Zenke M., Steinlein P., Wagner E., Cotten M., Beug H., Birnstiel M.L.: Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells, Proc. Natl. Acad. Sci. USA 87, 3655-3659, 1990.
26. Branden L.J., Mohamed A.J., Smith C.I.: A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA, Nat. Biotechnol. 17, 784-787, 1999. (Pubitemid 29365107)
27. Kaneda Y., Saeki Y., Morishita R.: Gene therapy using HVJ-liposomes: the best of both worlds?, Mol. Med. Today 5, 298-303, 1999. (Pubitemid 29302677)
28. Fasbender A., Zabner J., Chillon M., Moninger T.O., Puga A.P., Davidson B.L., Welsh M.J.: Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo, J. Biol. Chem. 272, 6479-6489, 1997. (Pubitemid 27118128)
29. Kaneda Y., Iwaki K., Uchida T.: Increased expression of DNA cointroduced with nuclear protein in adult rat liver, Science. 243, 375-378, 1989. (Pubitemid 19047511)
30. Ueki T., Kaneda Y., Tsutsui H., Nakanishi K., Sawa Y., Morishita R., Matsumoto K., Nakamura T., Takahashi H., Okamoto S., Fujimoto, J.: Hepatocyte growth factor gene therapy of liver cirrhosis in rats, Nat. Med. 5, 226-230, 1999. (Pubitemid 29068532)
31. Kren B.T., Parashar B., Bandyopadhyay P., Roy Chowdhury N., Roy Chowdhury J., Steer C.J.: Correction of the UDP-glucoronyltransferase gene defect in the gunn rat model of crigler najjar syndrome type I with a chimeric oligonucleotide, Proc. Natl. Acad. Sci. USA 96, 10349-10354, 1999. (Pubitemid 29422561)
32. Kay M.A., Glorioso J.C., Naldini L.: Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics, Nat. Med. 7, 33-40, 2001. (Pubitemid 32095639)
33. Engelhardt J.F., Ye X., Doranz B., Wilson J.M.: Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver, Proc. Natl. Acad. Sci. USA 91, 6196-6200, 1994. (Pubitemid 24188310)
34. Kochanek S., Clemens P.R., Mitani K., Chen H.H., Chan S., Caskey C.T.: A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase, Proc. Natl. Acad. Sci. USA 93, 5731-5736, 1996.
35. Bunting K.D., Sangster M.Y., Ihle J.N., Sorrentino, B.P.: Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer, Nat. Med. 4, 58-64, 1998. (Pubitemid 28133080)
36. Enomaa N., Danos O., Peltonen L., Jalanko A.: Correction of deficient enzyme activity in a lysosomal storage disease, aspartylglucosaminuria, by enzyme replacement and retroviral gene transfer, Hum. Gene. Ther. 6, 723-731, 1995.
37. Moullier P., Bohl D., Heard J.M., Danos O.: Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts, Nat. Genet. 4, 154-159, 1993. (Pubitemid 23179099)
38. Krall W.J., Challita P.M., Perlmutter L.S., Skelton D.C., Kohn D.B.: Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation, Blood. 83, 2737-2748, 1994. (Pubitemid 24135869)
39. Pichard V., Aubert D., Ferry N.: Efficient retroviral gene transfer to the liver in vivo using nonpolypeptidic mitogens, Biochem. Biophys. Res. Commun. 286, 929-935, 2001. (Pubitemid 32926750)
40. Gray D.A.: Insertional mutagenesis: neoplasia arising from retroviral integration, Cancer Invest. 9, 295-304, 1991.
41. Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., Gross F., Yvon E., Nusbaum P., Selz F., Hue C., Certain S., Casanova J.L., Bousso P., Deist F.L., Fischer A.: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease, Science 288, 669-672, 2000. (Pubitemid 30241569)
42. Buchschacher G.L., Jr, .Wong-Staal F.: Development of lentiviral vectors for gene therapy for human diseases, Blood. 95, 2499-2504, 2000.
43. Kafri T., Blomer U., Peterson D.A., Gage F.H., Verma I.M.: Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors, Nat. Genet. 17, 314-317, 1997. (Pubitemid 27475995)
44. Consiglio A., Quattrini A., Martino S., Bensadoun J.C., Dolcetta D., Trojani A., Benaglia G., Marchesini S., Cestari V., Oliverio A., Bordignon C., Naldini L.: In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice, Nat. Med. 7, 310-316, 2001. (Pubitemid 32224346)
45. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., Aebischer P.: Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease, Science 290, 767-773, 2000.
46. Trono D.: Lentiviral vectors: turning a deadly foe into a therapeutic agent, Gene. Ther. 7, 20-23, 2000.
47. May C., Rivella S., Callegari J., Heller G., Gaensler K.M., Luzzatto L., Sadelain M.: Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin, Nature. 406, 82-86, 2000. (Pubitemid 30460215)
48. Dull T., Zufferey R., Kelly M., Mandel R.J., Nguyen M., Trono D., Naldini L.: A third-generation lentivirus vector with a conditional packaging system, J. Virol. 72, 8463-8471, 1998. (Pubitemid 28471781)
49. Zufferey R., Dull T., Mandel R.J., Bukovsky A., Quiroz D., Naldini L., Trono D.: Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery, J. Virol. 72, 9873-9880, 1998. (Pubitemid 28520853)
50. Bueler H.: Adeno-associated viral vectors for gene transfer and gene therapy, Biol. Chem. 380, 613-622, 1999.
51. Monahan P.E., Samulski R.J.: AAV vectors: is clinical success on the horizon?, Gene. Ther. 7, 24-30, 2000. (Pubitemid 30077145)
52. Snyder R.O., Miao C., Meuse L., Tubb J., Donahue B.A., Lin H.F., Stafford D.W., Patel S., Thompson A.R., Nichols T., Read M.S., Bellinger D.A., Brinkhous K.M., Kay M.A.: Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors, Nat. Med. 5, 64-70, 1999. (Pubitemid 29051000)
53. Herzog R.W., Yang E.Y., Couto L.B., Hagstrom J.N., Elwell D., Fields P.A., Burton M., Bellinger D.A., Read M.S., Brinkhous K.M., Podsakoff G.M., Nichols T.C., Kurtzman G.J., High K.A.: Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector, Nat. Med. 5, 56-63, 1999. (Pubitemid 29050999)
54. Greelish J.P., Su L.T., Lankford E.B., Burkman J.M., Chen H., Konig S.K., Mercier I.M., Desjardins P.R., Mitchell M.A., Zheng X.G., Leferovich J., Gao G.P., Balice-Gordon R.J., Wilson J.M., Stedman H.H.: Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector, Nat. Med. 5, 439-443, 1999. (Pubitemid 29180585)
55. Kay M.A., Manno C.S., Ragni M.V., Larson P.J., Couto L.B., McClelland A., Glader B., Chew A.J., Tai S.J., Herzog R.W., Arruda V., Johnson F., Scallan C., Skarsgard E., Flake A.W., High K.A.: Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector, Nat. Genet. 24, 257-261, 2000. (Pubitemid 30132193)
56. Stedman H., Wilson J.M., Finke R., Kleckner A.L., Mendell J.: Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors, Hum. Gene. Ther. 11, 777-790, 2000. (Pubitemid 30180282)
57. Flotte T., Carter B., Conrad C., Guggino W., Reynolds T., Rosenstein B., Taylor G., Walden S., Wetzel R.: A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease, Hum. Gene. Ther. 7, 1145-1159, 1996. (Pubitemid 26202733)
58. Matsushita T., Elliger S., Elliger C., Podsakoff G., Villarreal L., Kurtzman G.J., Iwaki Y., Colosi P.: Adeno-associated virus vectors can be efficiently produced without helper virus, Gene. Ther. 5, 938-945, 1998. (Pubitemid 28371911)
59. Gao G.P., Qu G., Faust L.Z., Engdahl R.K., Xiao W., Hughes J.V., Zoltick P.W., Wilson J.M.: High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus, Hum. Gene. Ther. 9, 2353-2362, 1998. (Pubitemid 28523984)
60. Allen J.M., Halbert C.L., Miller A.D.: Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6, Mol. Ther. 1, 88-95, 2000.
61. Yan Z., Zhang Y., Duan D., Engelhardt J.F.: Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy, Proc. Natl. Acad. Sci. USA 97, 6716-6721, 2000. (Pubitemid 30412780)
62. Duan D., Yue Y., Yan Z., Engelhardt J.F.: A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation, Nat. Med. 6, 595-598, 2000. (Pubitemid 30305913)
63. Young L.S., Mautner V.: The promise and potential hazards of adenovirus gene therapy, Gut. 48, 733-736, 2001. (Pubitemid 32378601)
64. Brenner M.: Gene transfer by adenovectors, Blood. 94, 3965-3967, 1999.
65. Lal S., Lauer U.M., Niethammer D., Beck J.F., Schlegel P.G.: Suicide genes: past, present and future perspectives, Immunol. Today. 21, 48-54, 2000. (Pubitemid 30410699)
66. Zwiebel J.A.: Cancer gene and oncolytic virus therapy, Semin. Oncol. 28, 336-343, 2001.
67. Geutskens S.B., van der Eb M.M., Plomp A.C., Jonges L.E., Cramer S.J., Ensink N.G., Kuppen P.J., Hoeben R.C.: Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells, Gene. Ther. 7, 1410-1416, 2000. (Pubitemid 30662247)
68. Yoon S.K., Armentano D., Wands J.R., Mohr L.: Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice, Cancer Gene. Ther. 8, 573-579, 2001. (Pubitemid 32786560)
69. Schiedner G., Morral N., Parks R.J., Wu Y., Koopmans S.C., Langston C., Graham F.L., Beaudet A.L., Kochanek S.: Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity, Nat. Genet. 18, 180-183, 1998. (Pubitemid 28082470)
70. Cheshenko N., Krougliak N., Eisensmith R.C., Krougliak V.A.: A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus, Gene. Ther. 8, 846-854, 2001. (Pubitemid 32577189)
71. Krasnykh V., Dmitriev I., Navarro J.G., Belousova N., Kashentseva E., Xiang J., Douglas J.T., Curiel D.T.: Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity, Cancer Res. 60, 6784-6787, 2000. (Pubitemid 32059138)
72. During M.J., Naegele J.R., O'Malley K.L., Geller A.I.: Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase, Science 266, 1399-1403, 1994.
73. Goins W.F., Lee K.A., Cavalcoli J.D., O'Malley M.E., DeKosky S.T., Fink D.J., Glorioso J.C.: Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity, J. Virol. 73, 519-532, 1999. (Pubitemid 28565397)
74. Yamada M., Oligino T., Mata M., Goss J.R., Glorioso J.C., Fink D.J.: Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo, Proc. Natl. Acad. Sci. USA 96, 4078-4083, 1999. (Pubitemid 29169039)
75. Poliani P.L., Brok H., Furlan R., Ruffini F., Bergami A., Desina G., Marconi P.C., Rovaris M., Uccelli A., Glorioso J.C., Penna G., Adorini L., Comi G., Hart B., Martino G.: Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis, Hum. Gene. Ther. 12, 905-920, 2001. (Pubitemid 32681855)
76. Samaniego L.A., Neiderhiser L., DeLuca N.A.: Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins, J. Virol. 72, 3307-3320, 1998. (Pubitemid 28175576)
77. Logvinoff C., Epstein A.L.: A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus, Hum. Gene. Ther. 12, 161-167, 2001. (Pubitemid 32095454)
78. Herrlinger U., Jacobs A., Quinones A., Woiciechowsky C., Sena-Esteves M., Rainov N.G., Fraefel C., Breakefield X.O.: Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma, Hum. Gene. Ther. 11, 1429-1438, 2000. (Pubitemid 30451023)
79. Bischoff J.R., Kirn D.H., Williams A., Heise C., Horn S., Muna M., Ng L., Nye J.A., Sampson-Johannes A., Fattaey A., McCormick F.: An adenovirus mutant that replicates selectively in p53-deficient human tumor cells, Science 274, 373-376, 1996. (Pubitemid 26353341)
80. Kirn D.: Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?, Gene. Ther. 8, 89-98, 2001.
81. Khuri F.R., Nemunaitis J., Ganly I., Arseneau J., Tannock I.F., Romel L., Gore M., Ironside J., MacDougall R.H., Heise C., Randlev B., Gillenwater A.M., Bruso P., Kaye S.B., Hong W.K., Kirn D.H.: a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer, Nat. Med. 6, 879-885, 2000. (Pubitemid 30644745)
82. Lamont J.P., Nemunaitis J., Kuhn J.A., Landers S.A., McCarty T.M.: A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience), Ann. Surg. Oncol. 7, 588-592, 2000.
83. Yoon S.S., Nakamura H., Carroll N.M., Bode B.P., Chiocca E.A., Tanabe K.K.: An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma, Faseb. J. 14, 301-311, 2000. (Pubitemid 30086067)
84. Mineta T., Rabkin S.D., Yazaki T., Hunter W.D., Martuza R.L.: Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas, Nat. Med. 1, 938-943, 1995.
85. Coffey M.C., Strong J.E., Forsyth P.A., Lee P.W.: Reovirus therapy of tumors with activated Ras pathway, Science 282, 1332-1334, 1998. (Pubitemid 28524498)
86. Freytag S.O., Rogulski K.R., Paielli D.L., Gilbert J.D., Kim J.H.: A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy, Hum. Gene. Ther. 9, 1323-1333, 1998. (Pubitemid 28312897)
87. Todo T., Martuza R.L., Dallman M.J., Rabkin S.D.: In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity, Cancer Res. 61, 153-161, 2001. (Pubitemid 32095713)
88. Nakamura H., Mullen J.T., Chandrasekhar S., Pawlik T.M., Yoon S.S., Tanabe K.K.: Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil, Cancer Res. 61, 5447-5452, 2001. (Pubitemid 32694925)